The Food and Drug Administration today released for comment draft guidance clarifying what types of clinical and patient decision support software would no longer be regulated by the agency as a medical device under the 21st Century Cures Act. FDA Commissioner Scott Gottlieb, M.D., said the guidance generally excludes from regulation software that allows a health care provider or patient to independently review the basis for its treatment recommendations. In addition, FDA released draft guidance clarifying that certain digital health technologies, such as mobile apps intended solely to maintain or encourage a healthy lifestyle, generally fall outside the scope of FDA regulation under the Act, and final guidance adopting international principles for harmonizing the regulation of software with a medical purpose.

Related News Articles

Headline
The Health and Public Health Sector Coordinating Council, a public-private partnership, yesterday released a crisis response guide to help health care…
Headline
The Healthcare and Public Health Sector Coordinating Council, a public-private partnership developed to mitigate threats to the nation’s health care sector,…
Headline
China and its proxies have been observed attempting to identify and illicitly obtain valuable intellectual property and public health data related to vaccines…
Headline
AHA yesterday urged the Federal Communications Commission to grant expedited approval to its request that the agency extend the COVID-19 Telehealth Program to…
Headline
The Department of Homeland Security and the Cybersecurity and Infrastructure Security Agency have updated their telework guidance to include new guidance on…
Headline
Cyber actors have launched phishing campaigns against first responders, initiated denial-of-service assaults against government agencies and threatened medical…